20/20 Biolabs Inc. (AIDX) vs CollPlant Biotechnologies Ltd. (CLGN)
A side-by-side comparison of 20/20 Biolabs Inc. and CollPlant Biotechnologies Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIDX
20/20 Biolabs Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 3:33 PM EDT
CLGN
CollPlant Biotechnologies Ltd.
$3.30HealthcareDelayed quote: Oct 6, 2026, 3:33 PM EDT
Total return — AIDX vs CLGN
growth of $100 · dividends reinvested · last 1yAIDX -98.5% (-98.5%/yr)CLGN -46.2% (-46.2%/yr)CLGN compounded faster over this window
Log scale — wide-divergence pair
AIDX CLGN
AIDX vs CLGN: by the numbers
- •AIDX is the larger company ($4M vs $4M market cap).
- •Both run net losses; AIDX's is the smaller (-285.00% vs -3934.91% net margin).
- •Both shrank revenue over the past five years; AIDX's decline was smaller (-2.58% vs -56.28% CAGR).
Metrics side by side
Valuation
| Metric | AIDX | CLGN |
|---|---|---|
| P/S ratio | 2.17 | 13.44 |
| P/B ratio | 2.74 | 1.45 |
Profitability
| Metric | AIDX | CLGN |
|---|---|---|
| Gross margin | 31.52% | 26.32% |
| Operating margin | -162.87% | -484.31% |
| Net margin | -285.00% | -3934.91% |
| ROE | -184.04% | -424.89% |
| ROIC | -116.89% | -221.32% |
Growth (annualized)
| Metric | AIDX | CLGN |
|---|---|---|
| Revenue CAGR (5Y) | -2.58% | -56.28% |
| Total return CAGR (5Y) | N/A | -53.69% |
Frequently asked
- Which has grown faster, AIDX or CLGN?
- Neither grew: over the past five years both shrank revenue, with AIDX's decline the smaller — AIDX at a -2.58% CAGR versus CLGN at -56.28%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.